CompletedNot Applicable

Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment of Frozen Shoulder

Taiwan90 participantsStarted 2022-08-01

Plain-language summary

Frozen shoulder, adhesive capsulitis, shoulder, platelet-rich plasma, corticosteroid, injection.

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. age between 20 to 80 years old;
✓. shoulder pain for ≥ 1 month;
✓. \> 30% loss of passive range of motion (ROM) of the affected shoulder in external rotation and/or abduction, comparing with the sound side;
✓. visual analog scale for pain on maximal passive external rotation or abduction \> 4;
✓. an empty or soft end feel on passive external rotation, or abduction and/or presence of night pain or rest pain;
✓. showing willing to attend regular physical therapy programs for 8 weeks.

✕. severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
✕. uncontrolled DM;
✕. rotator cuff tear or calcification of the affected shoulder;
✕. fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
✕. a hard end feel on passive external rotation or abduction of the affected shoulder;
✕. a history of drug allergy to local anesthetics or corticosteroids;
✕. receiving corticosteroid or hyaluronic acid joint or bursa injection of the affected shoulder during the preceding three months.

The Shoulder Pain and Disability Index (SPADI)

Timeframe: Change between baseline and at 1 months, 2 months, 4 months, 6 months after the beginning of the treatment.

NCT IDNCT05230667

SponsorShin Kong Wu Ho-Su Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-31

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. age between 20 to 80 years old;
✓. shoulder pain for ≥ 1 month;
✓. \> 30% loss of passive range of motion (ROM) of the affected shoulder in external rotation and/or abduction, comparing with the sound side;
✓. visual analog scale for pain on maximal passive external rotation or abduction \> 4;
✓. an empty or soft end feel on passive external rotation, or abduction and/or presence of night pain or rest pain;
✓. showing willing to attend regular physical therapy programs for 8 weeks.

✕. severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
✕. uncontrolled DM;
✕. rotator cuff tear or calcification of the affected shoulder;
✕. fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
✕. a hard end feel on passive external rotation or abduction of the affected shoulder;
✕. a history of drug allergy to local anesthetics or corticosteroids;
✕. receiving corticosteroid or hyaluronic acid joint or bursa injection of the affected shoulder during the preceding three months.